Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 019887
Company: FRESENIUS KABI USA
Company: FRESENIUS KABI USA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| NEBUPENT | PENTAMIDINE ISETHIONATE | 300MG/VIAL | FOR SOLUTION;INHALATION | Prescription | AN | Yes | Yes |
| NEBUPENT | PENTAMIDINE ISETHIONATE | 600MG/VIAL | FOR SOLUTION;INHALATION | Discontinued | None | No | No |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 02/08/2011 | SUPPL-14 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019887s014lbl.pdf |